Oncolytics Biotech Inc (ONCY)

Get an in-depth profile of Oncolytics Biotech Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

1.230 -0.040 (-3.15%)

19:00:38 Real-time Cboe USD Disclaimer

Oncolytics Biotech Inc Company Profile

Industry: Biotechnology & Medical Research
Sector: Healthcare
Employees: -
Equity Type: ORD

Oncolytics Biotech Inc. is a biotechnology company. The Company is engaged in developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. It improves the ability of the immune system to fight cancer, making tumors susceptible to a range of oncology treatments. The Company is conducting clinical trials evaluating pelareorep in combination with checkpoint inhibitors and targeted therapies in solid and hematological malignancies. Pelareorep’s anti-tumor activity is based on three modes: selective viral replication in permissive cancer cells, which leads to tumor cell lysis; activation of innate immunity in response to the infection, which results in a cascade of chemokines/cytokines, causing natural killer (NK) cells to be activated and attack cancer cells; and specific adaptive immune response triggered by tumor and viral-associated antigens displayed by antigen presenting cells.

Contact Information

Address: Calgary,T2R 0C5 Canada
Phone: -
Fax: -
Web: https://www.oncolyticsbiotech.com

Top Executives

Name	Age	Since	Title
James T. Parsons	57	2022	Independent Director
Jonathan M. N. Rigby	54	2022	Director

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.